World Health Organization Regional Office for South-East Asia

 

 

 

 

 

 

 

A

 

Communicable Diseases Department

 

Profile and Vision

 

Organogram

 

Disease Surveillance & Epidemiology (DSE)

 

Surveillance and Outbreak Alert

 

International Health Regulations

 

Laboratory support

 

DSE subunit Bangkok

 

Prevention & control of priority communicable diseases

 

HIV/AIDS

 

Tuberculosis

 

Malaria

 

Transfusion transmitted infections

 

Elimination and eradication of tropical diseases

 

Leprosy

 

Dengue Fever

 

Lymphatic filariasis & Soil-transmitted Helminthiasis

 

Kala azar

 

Yaws

Influenza A (H1N1)

 

Chronology of Influenza A (H1N1)

 

May 2009

 

May 1

Influenza_A(H1N1)SEARO holds Video Conference with all WHO representatives in 11 Member States of the Region.

Mexico begins a five-day shutdown at the start of a May Day weekend to try to contain a flu epidemic which the government now says appeared to be "not so aggressive" as initially feared.

The first confirmed case of swine flu in Asia is recorded in Hong Kong after a Mexican man who arrived via Shanghai tested positive. Guests and staff at the hotel where he had stayed are placed under quarantine for a week.

WHO says it has "no doubt" that a successful vaccine against the swine flu virus could be developed within the next six months.

May 2 

Mexico says the flu epidemic appears to be "in a stabilization phase", but the toll in the country rises to 19 dead and 454 confirmed infections. WHO says 16 countries have officially reported 658 confirmed cases of influenza A(H1N1), but that there is no indication that it has begun to spread in a sustained manner anywhere outside of

North America.

Canada on 2 May reported the identification of the A(H1N1) virus in a swine herd in Alberta. It is highly probable that the pigs were exposed to the virus from a Canadian farm worker recently returned from Mexico, who had exhibited flu-like symptoms and had contact with the pigs. Three new countries (Costa Rica, France and Republic of Korea) have reported cases (one, two and one respectively).

May 3

Influenza_A(H1N1)WHO says 18 countries have officially reported 898 cases of influenza A(H1N1) infection. WHO’s Director-General informs Regional Directors of decision to deploy Oseltamivir to 72 least developed countries.

 

 

 

Back

May 4

WHO says 21 countries have officially reported 1085 cases of influenza A (H1N1) infection, 26 deaths.

Three new countries (Colombia, El Salvador, and Italy) have reported cases (one, two and two respectively).

WHO Director-general addresses the UN General Assembly: stresses uncertainty, lessons from past pandemics, limited amount of antivirals and vaccines, and the need for solidarity

May 5

WHO reports 1490 cases from 21 countries and 30 deaths.

WHO dispatches 2.4 million courses of antivirals to 72 countries most in need, including Mexico. These were dispatched from Geneva and Basel in Switzerland, Maryland in the US and Dubai in the United Arab Emirates.

Scientific Committee meets to discuss a range of issues including the development of the Influenza A (H1N1) virus and issues around its severity.

May 6

WHO reports 1893 cases from 23 countries and 31 deaths. Two new countries (Guatemala and Sweden) have reported cases (one each).

WHO SEARO distributed about 60,000 doses of Oseltamivir and Personal Protection Equipment to its Member States.

May 7

Influenza_A(H1N1)WHO reports 2371 cases from 24 countries with 44 deaths.

One new country (Poland) confirms one case of A/H1N1.

Dr Keiji Fukuda, Assistant Director General ai, Health Security and Environment, briefs Association of Southeast Asian Nations (ASEAN) members at Special Health Ministers meeting in Bangkok on WHO's pandemic response and the implications of moving from phase 5 to phase 6.

Editorial in Nature praises WHO's communications efforts in the A/H1N1 response.

May 8

WHO reports 2500 cases from 25 countries and 46 deaths.

One new country (Brazil) confirms four cases of A/H1N1.

WHO Director-General addresses the ASEAN+3 Health Ministers' Special Meeting on A/H1N1 via video link.

May 9

WHO reports 3453 cases from 29 countries and 48 deaths.

Four new countries (Argentina, Australia, Japan and Panama) confirm cases of A/H1N1.

May 10

WHO reports 4393 cases from 30 countries 42 deaths.

One new country (Norway) confirms two cases.

Number of news stories on the topic down to about 25% of peak.

Teleconference held with the International Federation of Pharmaceutical.

Manufacturers and Associations (IFPMA), the Developing Countries Vaccine Manufacturers' Network, and other influenza vaccine manufacturers to review the latest information about biosecurity and conditions for working with vaccine viruses, and the availability of these strains.

Back

May 11

WHO reports 4789 cases from 30 countries and 53 deaths.

May 12

WHO reports 5269 cases from 30 countries and 61 deaths.

Thailand confirms its first two cases of H1N1 at a press conference at 1400 hours BKK time. The two teenagers had recently returned from Mexico. Eighteen passengers on the same flight who sat close to the two teenagers were contacted and given oseltamivir.

May 13

WHO reports 6302 cases from 33 countries.

Three new countries (Cuba (1), Finland (2) and Thailand (2) ) confirm cases.

The "Gibbs article" hypothesizing on the origin of the new H1N1 virus suggests that the virus might have grown in eggs and released in an accident.

May 14

WHO reports 7457 cases from 34 countries, and 65 deaths.

One new country (Belgium) confirms one case.

Indian Drug manufacturer, Cipla, receives pre-qualification by WHO for production of oseltamivir. Prequalification means that Cipla's product meets WHO standards for quality.

A vaccine advisory group meeting held at WHO HQ. The objective is to ascertain whether enough evidence exists to recommend large-scale A(H1N1) vaccine production.

May 15

Influenza_A(H1N1)34 countries have officially reported 7520 cases of influenza A(H1N1) infection and 65 deaths.

Of the 72 countries and six WHO regional offices where WHO sent a total of 3 million antiviral doses from its global stockpile on 5 May, all deliveries have been made except for seven countries (Burkina Faso, Niger, Cuba, Pakistan, DPRK, Honduras and Indonesia).

Start of Inter-government meeting on Virus Sharing held to address novel influenza virus sharing and benefits like vaccines and anti-virals.

 May 16

India’s first confirmed case of H1N1 reported. The 23-year-old male passenger from New York, USA arrived in Hyderabad on Wednesday 13 May. His laboratory sample was confirmed. He was shifted to an isolation facility and treated with oseltamivir and has since recovered.

May 17

39 countries have officially reported 8480 cases of influenza A(H1N1) infection and 72 deaths to WHO.

Japan reports 21 new confirmed cases from students at three high schools in Kobe and nine students at a high school in Osaka. All the new cases appear to have acquired the virus independently and have not traveled recently to countries affected by influenza A(H1N1).

Back

May 18

Japan reports 118 new cases over the last 24 hours.

Sixty second World Health Assembly begins in Geneva. At the start of the session, several Member States ask that WHO reflect and consider before moving to Phase 6.

All 72 countries receive their consignments of oseltamivir antiviral courses that WHO started sending on 5 May. WHO sent 3 million courses of the drug.

May 19

Health Ministers from 11 Member States of the South East Asia Region adopt a joint statement during the sixty second session of the WHA towards concerted policy action to minimize the impact of the potential influenza pandemic in the Region.

UN Secretary General Ban Ki-moon and WHO Director General Dr Margaret Chan meet with around 30 pharmaceutical manufacturers and discuss the need for equity and fairness in access to vaccines for developing countries.

May 21

Influenza_A(H1N1)High profile meetings – WHA: Agenda item 12.1 on Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits." Member States call on WHO Director General to consider giving "extra flexibility" for deciding on Phase levels under IHR.

 

May 22

Sixty second World Heath Assembly concludes with the Director General emphasizing that –“the decision to declare an influenza pandemic is a responsibility, and a duty, that she takes seriously”.

Weekly Epidemiological Record issued today has particular focus on Clinical observations on H1N1 patients.

 

Back

 

||| | ||